Wozel G, Julius U
Dtsch Z Verdau Stoffwechselkr. 1982;42(2-3):85-93.
A 25-year-old woman with progressive systemic sclerosis was treated with D-penicillamine. (DPA) 30 days after starting therapy cholestatic jaundice was observed. Moreover, for two years she has taken the pill. Both drugs were discontinued, the jaundice disappeared and the laboratory findings of liver became normal. A rechallenge of D-penicillamine after 9 months induced no reaction. An underlying chronic liver disease before cholestasis could be excluded by liver biopsy. Allergic cutantests and lymphocyte transformation test with D-penicillamine and penicillin gave normal results. The frequency of cholestatic jaundice caused by DPA-therapy is discussed and the possible pathomechanism analyzed.
一名25岁患有进行性系统性硬化症的女性接受了D-青霉胺治疗。开始治疗30天后出现胆汁淤积性黄疸。此外,她服用避孕药已有两年。两种药物均停用后,黄疸消失,肝脏实验室检查结果恢复正常。9个月后再次使用D-青霉胺未引发反应。肝活检排除了胆汁淤积前存在潜在慢性肝病的可能。D-青霉胺和青霉素的变应性皮肤试验及淋巴细胞转化试验结果均正常。文中讨论了D-青霉胺治疗引起胆汁淤积性黄疸的发生率,并分析了可能的发病机制。